JP Stock MarketDetailed Quotes

7062 Fureasu

Watchlist

1079
-2-0.19%

20min DelayMarket Closed Dec 30 15:30 JST

2.54BMarket Cap43.95P/E (Static)

Fureasu Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

24.56%5.71B

23.32%1.49B

27.17%1.48B

24.13%1.37B

23.62%1.36B

9.81%4.58B

22.16%1.21B

4.80%1.17B

5.94%1.1B

7.23%1.1B

Cost of revenue

28.52%3.02B

31.99%815.12M

32.12%783.84M

25.57%725.1M

23.91%691.19M

11.95%2.35B

18.15%617.56M

8.23%593.27M

13.41%577.43M

8.17%557.81M

Gross profit

20.41%2.69B

14.31%679.87M

22.03%698.16M

22.54%645.57M

23.31%671.18M

7.66%2.24B

26.63%594.76M

1.47%572.13M

-1.19%526.84M

6.28%544.29M

Operating expense

16.24%2.58B

15.64%650.17M

17.21%669.93M

19.08%649.9M

12.98%614.17M

17.35%2.22B

15.86%562.24M

18.11%571.58M

13.58%545.79M

22.21%543.61M

Operating profit

647.53%110.6M

-8.69%29.7M

5,088.97%28.23M

77.16%-4.33M

8,295.58%57.01M

-91.97%14.8M

308.19%32.52M

-99.32%544K

-136.01%-18.95M

-98.99%679K

Net non-operating interest income (expenses)

-187.31%-38.93M

-140.06%-13.3M

-160.45%-10.93M

-252.62%-8.14M

-336.01%-6.56M

-107.35%-13.55M

-273.63%-5.54M

-137.93%-4.2M

-51.48%-2.31M

14.73%-1.51M

Non-operating interest expense

187.31%38.93M

140.06%13.3M

160.45%10.93M

252.62%8.14M

336.01%6.56M

107.35%13.55M

273.63%5.54M

137.93%4.2M

51.48%2.31M

-14.73%1.51M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-115.92%-2.98M

-46.87%18.72M

18.72M

Less:Other special charges

----

46.87%-18.72M

----

Less:Write off

--2.98M

----

--0

----

Other non-operating income (expenses)

-21.16%54.89M

-70.45%6.01M

-16.12%35.86M

418.81%7.53M

8.14%5.49M

53.09%69.62M

463.60%20.35M

9.39%42.75M

35.86%1.45M

195.46%5.07M

Income before tax

37.94%123.58M

-70.59%19.43M

35.97%53.16M

75.08%-4.94M

1,217.24%55.93M

-65.33%89.59M

589.43%66.05M

-66.66%39.1M

-126.61%-19.81M

-94.71%4.25M

Income tax

12.53%65.27M

-53.88%11.96M

-6.30%21.54M

159.14%5.09M

275.00%26.69M

-47.55%58M

389.66%25.94M

-46.06%22.98M

-94.25%1.96M

-75.04%7.12M

Net income

84.59%58.31M

-81.40%7.46M

96.23%31.62M

53.95%-10.02M

1,118.99%29.25M

-78.64%31.59M

313.42%40.11M

-78.41%16.12M

-154.05%-21.77M

-105.55%-2.87M

Net income continuous operations

84.59%58.31M

-81.40%7.46M

96.25%31.62M

53.96%-10.02M

1,118.99%29.25M

-78.64%31.59M

313.42%40.11M

-78.42%16.11M

-154.05%-21.77M

-105.55%-2.87M

Noncontrolling interests

Net income attributable to the company

84.59%58.31M

-81.40%7.46M

96.23%31.62M

53.95%-10.02M

1,118.99%29.25M

-78.64%31.59M

313.42%40.11M

-78.41%16.12M

-154.05%-21.77M

-105.55%-2.87M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

84.59%58.31M

-81.40%7.46M

96.23%31.62M

53.95%-10.02M

1,118.99%29.25M

-78.64%31.59M

313.42%40.11M

-78.41%16.12M

-154.05%-21.77M

-105.55%-2.87M

Gross dividend payment

Basic earnings per share

84.24%24.78

-81.44%3.17

95.63%13.44

54.05%-4.26

1,110.57%12.43

-78.75%13.45

311.91%17.08

-78.50%6.87

-153.80%-9.27

-105.55%-1.23

Diluted earnings per share

84.03%24.55

-81.58%3.14

94.45%13.32

54.05%-4.26

1,101.63%12.32

-78.62%13.34

311.53%17.0497

-78.25%6.8501

-154.72%-9.27

-105.63%-1.23

Dividend per share

0.00%10.57

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	24.56%5.71B	23.32%1.49B	27.17%1.48B	24.13%1.37B	23.62%1.36B	9.81%4.58B	22.16%1.21B	4.80%1.17B	5.94%1.1B	7.23%1.1B
Cost of revenue	28.52%3.02B	31.99%815.12M	32.12%783.84M	25.57%725.1M	23.91%691.19M	11.95%2.35B	18.15%617.56M	8.23%593.27M	13.41%577.43M	8.17%557.81M
Gross profit	20.41%2.69B	14.31%679.87M	22.03%698.16M	22.54%645.57M	23.31%671.18M	7.66%2.24B	26.63%594.76M	1.47%572.13M	-1.19%526.84M	6.28%544.29M
Operating expense	16.24%2.58B	15.64%650.17M	17.21%669.93M	19.08%649.9M	12.98%614.17M	17.35%2.22B	15.86%562.24M	18.11%571.58M	13.58%545.79M	22.21%543.61M
Operating profit	647.53%110.6M	-8.69%29.7M	5,088.97%28.23M	77.16%-4.33M	8,295.58%57.01M	-91.97%14.8M	308.19%32.52M	-99.32%544K	-136.01%-18.95M	-98.99%679K
Net non-operating interest income (expenses)	-187.31%-38.93M	-140.06%-13.3M	-160.45%-10.93M	-252.62%-8.14M	-336.01%-6.56M	-107.35%-13.55M	-273.63%-5.54M	-137.93%-4.2M	-51.48%-2.31M	14.73%-1.51M
Non-operating interest expense	187.31%38.93M	140.06%13.3M	160.45%10.93M	252.62%8.14M	336.01%6.56M	107.35%13.55M	273.63%5.54M	137.93%4.2M	51.48%2.31M	-14.73%1.51M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-115.92%-2.98M	-115.92%-2.98M				-46.87%18.72M	18.72M
Less:Other special charges	----	----	----	----	----	46.87%-18.72M	----	----	----	----
Less:Write off	--2.98M	----	----	----	----	--0	----	----	----	----
Other non-operating income (expenses)	-21.16%54.89M	-70.45%6.01M	-16.12%35.86M	418.81%7.53M	8.14%5.49M	53.09%69.62M	463.60%20.35M	9.39%42.75M	35.86%1.45M	195.46%5.07M
Income before tax	37.94%123.58M	-70.59%19.43M	35.97%53.16M	75.08%-4.94M	1,217.24%55.93M	-65.33%89.59M	589.43%66.05M	-66.66%39.1M	-126.61%-19.81M	-94.71%4.25M
Income tax	12.53%65.27M	-53.88%11.96M	-6.30%21.54M	159.14%5.09M	275.00%26.69M	-47.55%58M	389.66%25.94M	-46.06%22.98M	-94.25%1.96M	-75.04%7.12M
Net income	84.59%58.31M	-81.40%7.46M	96.23%31.62M	53.95%-10.02M	1,118.99%29.25M	-78.64%31.59M	313.42%40.11M	-78.41%16.12M	-154.05%-21.77M	-105.55%-2.87M
Net income continuous operations	84.59%58.31M	-81.40%7.46M	96.25%31.62M	53.96%-10.02M	1,118.99%29.25M	-78.64%31.59M	313.42%40.11M	-78.42%16.11M	-154.05%-21.77M	-105.55%-2.87M
Noncontrolling interests
Net income attributable to the company	84.59%58.31M	-81.40%7.46M	96.23%31.62M	53.95%-10.02M	1,118.99%29.25M	-78.64%31.59M	313.42%40.11M	-78.41%16.12M	-154.05%-21.77M	-105.55%-2.87M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	84.59%58.31M	-81.40%7.46M	96.23%31.62M	53.95%-10.02M	1,118.99%29.25M	-78.64%31.59M	313.42%40.11M	-78.41%16.12M	-154.05%-21.77M	-105.55%-2.87M
Gross dividend payment
Basic earnings per share	84.24%24.78	-81.44%3.17	95.63%13.44	54.05%-4.26	1,110.57%12.43	-78.75%13.45	311.91%17.08	-78.50%6.87	-153.80%-9.27	-105.55%-1.23
Diluted earnings per share	84.03%24.55	-81.58%3.14	94.45%13.32	54.05%-4.26	1,101.63%12.32	-78.62%13.34	311.53%17.0497	-78.25%6.8501	-154.72%-9.27	-105.63%-1.23
Dividend per share	0.00%10.57	0.00%10.57	0	0	0	0.00%10.57	0.00%10.57	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.